Identification of Tissue of Origin in Cancer of Unknown Primary using a Targeted Bisulfite Sequencing Panel

References

• Rassy E , PavlidisN. Progress in refining the clinical management of cancer of unknown primary in the molecular era. Nat. Rev. Clin. Oncol.17(9), 541–554 (2020).
   PubMed Web of Science ®Google Scholar
• Kwee TC , KweeRM. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur. Radiol.19(3), 731–744 (2009).
   PubMed Web of Science ®Google Scholar
• Rassy E , PavlidisN. The currently declining incidence of cancer of unknown primary. Cancer Epidemiol.61, 139–141 (2019).
   PubMed Web of Science ®Google Scholar
• Park SY , KimBH , KimJH , LeeS , KangGH. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch. Pathol. Lab. Med.131(10), 1561–1567 (2007).
   PubMed Web of Science ®Google Scholar
• Kandalaft PL , GownAM. Practical applications in immunohistochemistry: carcinomas of unknown primary site. Arch. Pathol. Lab. Med.140(6), 508–523 (2016).
   PubMed Web of Science ®Google Scholar
• Kei S , AdeyiOA. Practical application of lineage-specific immunohistochemistry markers: transcription factors (sometimes) behaving badly. Arch. Pathol. Lab. Med.144(5), 626–643 (2020).
   PubMed Web of Science ®Google Scholar
• Tothill RW , KowalczykA , RischinDet al. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res.65(10), 4031–4040 (2005).
   PubMed Web of Science ®Google Scholar
• Ferracin M , PedrialiM , VeroneseAet al. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J. Pathol.225(1), 43–53 (2011).
   PubMed Web of Science ®Google Scholar
• Varadhachary GR , SpectorY , AbbruzzeseJLet al. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin. Cancer Res.17(12), 4063–4070 (2011).
   PubMed Web of Science ®Google Scholar
• Hainsworth JD , RubinMS , SpigelDRet al. Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon Research Institute. J. Clin. Oncol.31(2), 217–223 (2013).
   PubMed Web of Science ®Google Scholar
• Fernandez AF , AssenovY , Martin-SuberoJIet al. A DNA methylation fingerprint of 1628 human samples. Genome Res.22(2), 407–419 (2012).
   PubMed Web of Science ®Google Scholar
• Moran S , VizosoM , Martinez-CardúsAet al. Validation of DNA methylation profiling in formalin-fixed paraffin-embedded samples using the Infinium HumanMethylation450 Microarray. Epigenetics9(6), 829–833 (2014).
   PubMed Web of Science ®Google Scholar
• Moran S , Martinez-CardusA , SayolsSet al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol.17(10), 1386–1395 (2016).
   PubMed Web of Science ®Google Scholar
• Capper D , JonesDTW , SillMet al. DNA methylation-based classification of central nervous system tumours. Nature555(7697), 469–474 (2018).
   PubMed Web of Science ®Google Scholar
• Xia D , LeonAJ , CabaneroMet al. Minimalist approaches to cancer tissue-of-origin classification by DNA methylation. Mod. Pathol.33(10), 1874–1888 (2020).
   PubMed Web of Science ®Google Scholar
• Lu MY , ChenTY , WilliamsonDFKet al. AI-based pathology predicts origins for cancers of unknown primary. Nature594(7861), 106–110 (2021).
   PubMed Web of Science ®Google Scholar
• Schubert M , LindgreenS , OrlandoL. AdapterRemoval v2: rapid adapter trimming, identification, and read merging. BMC Res. Notes9, 88 (2016).
   PubMedGoogle Scholar
• Krueger F , AndrewsSR. Bismark: a flexible aligner and methylation caller for bisulfite-seq applications. Bioinformatics27(11), 1571–1572 (2011).
   PubMed Web of Science ®Google Scholar
• Virtanen P , GommersR , OliphantTEet al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods17(3), 261–272 (2020).
   PubMed Web of Science ®Google Scholar
• Walt SVD , ColbertSC , VaroquauxG. The NumPy array: a structure for efficient numerical computation. Comput. Sci. Eng.13(2), 22–30 (2011).
   Web of Science ®Google Scholar
• Pedregosa F , VaroquauxG , GramfortAet al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res.12(Oct), 2825–-2830 (2011).
   Google Scholar
• Valero-Mora PM . ggplot2: elegant graphics for data analysis. J. Stat. Softw.35(1), 1–3 (2010).
   PubMedGoogle Scholar
• McInnes L , HealyJ , MelvilleJ. UMAP: Uniform Manifold Approximation and Projection for dimension reduction. (2018).
   Google Scholar
• Anderson GG , WeissLM. Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance. Appl. Immunohistochem. Mol. Morphol.18(1), 3–8 (2010).
   PubMedGoogle Scholar
• Weiss LM , ChuP , SchroederBEet al. Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors. J. Mol. Diagn.15(2), 263–269 (2013).
   PubMed Web of Science ®Google Scholar
• Penson A , CamachoN , ZhengYet al. Development of genome-derived tumor type prediction to inform clinical cancer care. JAMA Oncol.6(1), 84–91 (2020).
   PubMed Web of Science ®Google Scholar
• Horlings HM , Van LaarRK , KerstJMet al. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. J. Clin. Oncol.26(27), 4435–4441 (2008).
   PubMed Web of Science ®Google Scholar
• Varadhachary GR , TalantovD , RaberMNet al. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J. Clin. Oncol.26(27), 4442–4448 (2008).
   PubMed Web of Science ®Google Scholar
• Kerr SE , SchnabelCA , SullivanPSet al. Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier. Clin. Cancer Res.18(14), 3952–3960 (2012).
   PubMed Web of Science ®Google Scholar
• Fizazi K , MaillardA , PenelNet al. LBA15_PR – a phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04). Ann. Oncol.30, v851 (2019).
   Web of Science ®Google Scholar
• Hayashi H , KurataT , TakiguchiYet al. Randomized phase II trial comparing site-specific treatment based on gene expression profiling with carboplatin and paclitaxel for patients with cancer of unknown primary site. J. Clin. Oncol.37(7), 570–579 (2019).
   PubMed Web of Science ®Google Scholar
• Ross JS , WangK , GayLet al. Comprehensive genomic profiling of carcinoma of unknown primary site: new routes to targeted therapies. JAMA Oncol.1(1), 40–49 (2015).
   PubMed Web of Science ®Google Scholar
• Hayashi H , TakiguchiY , MinamiHet al. Site-specific and targeted therapy based on molecular profiling by next-generation sequencing for cancer of unknown primary site: a nonrandomized phase 2 clinical trial. JAMA Oncol.6(12), 1931–1938 (2020).
   PubMed Web of Science ®Google Scholar
• Kacmarczyk TJ , FallMP , ZhangXet al. ‘Same difference’: comprehensive evaluation of four DNA methylation measurement platforms. Epigenetics Chromatin11(1), 21 (2018).
   PubMedGoogle Scholar
• Xia D , LeonAJ , CabaneroMet al. Minimalist approaches to cancer tissue-of-origin classification by DNA methylation. Mod. Pathol.33(10), 1874–1888 (2020).
   PubMed Web of Science ®Google Scholar
• Leitheiser M , CapperD , SeegererPet al. Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on DNA methylation. J. Pathol.256(4), 378–387 (2022).
   PubMed Web of Science ®Google Scholar
• Guo S , DiepD , PlongthongkumN , FungHL , ZhangK , ZhangK. Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. Nat. Genet.49(4), 635–642 (2017).
   PubMed Web of Science ®Google Scholar
• Kang S , LiQ , ChenQet al. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol.18(1), 53 (2017).
   PubMedGoogle Scholar
• Shen SY , SinghaniaR , FehringerGet al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature563(7732), 579–583 (2018).
   PubMed Web of Science ®Google Scholar
• Nassiri F , ChakravarthyA , FengSet al. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes. Nat. Med.26(7), 1044–1047 (2020).
   PubMed Web of Science ®Google Scholar
• Nuzzo PV , BerchuckJE , KorthauerKet al. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes. Nat. Med.26(7), 1041–1043 (2020).
   PubMed Web of Science ®Google Scholar
• Liu MC , OxnardGR , KleinEAet al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol.31(6), 745–759 (2020).
   PubMed Web of Science ®Google Scholar
• Sun Z , VaisvilaR , HussongLMet al. Nondestructive enzymatic deamination enables single-molecule long-read amplicon sequencing for the determination of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Genome Res.31(2), 291–300 (2021).
   PubMed Web of Science ®Google Scholar